Virtu Financial LLC Kura Oncology, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$9.62 - $13.99 $117,681 - $171,139	12,233 New	12,233 $129,000
Q1 2021 May 19, 2021	SELL	$24.75 - $39.14 $241,386 - $381,732	-9,753 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$29.0 - $41.62 $282,837 - $405,919	9,753 New	9,753 $319,000
Q4 2017 Feb 09, 2018	SELL	$13.5 - $16.65 $926,883 - $1.14 Million	-68,658 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$6.05 - $14.95 $415,380 - $1.03 Million	68,658	68,658 $1,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.